Cargando…

Undifferentiated uterine sarcoma metastatic to the brain

BACKGROUND: Undifferentiated uterine sarcoma (UUS) is a rare tumor with an aggressive growth pattern. They occur in women from 40 to 60 years and are generally characterized by poor prognosis, a high rate of local recurrence, and distant metastases. UUS accounts for 0.2% of all gynecological maligna...

Descripción completa

Detalles Bibliográficos
Autor principal: Stofko, Douglas L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815079/
https://www.ncbi.nlm.nih.gov/pubmed/24231690
http://dx.doi.org/10.4103/2152-7806.119054
_version_ 1782289357836648448
author Stofko, Douglas L
author_facet Stofko, Douglas L
author_sort Stofko, Douglas L
collection PubMed
description BACKGROUND: Undifferentiated uterine sarcoma (UUS) is a rare tumor with an aggressive growth pattern. They occur in women from 40 to 60 years and are generally characterized by poor prognosis, a high rate of local recurrence, and distant metastases. UUS accounts for 0.2% of all gynecological malignancies. Possible treatments include surgery, radiotherapy, and chemotherapy. CASE DESCRIPTION: A 65-year-old female with postmenopausal bleeding was found to have a uterine mass for which she underwent a total abdominal hysterectomy, bilateral salpingo-oophorectomy, and omentectomy. The pathologic evaluation was consistent with undifferentiated endometrial sarcoma. She began experiencing headaches with associated visual disturbances. Magnetic resonance imaging (MRI) of the brain showed a homogenous enhancing occipital dural-based mass measuring 1.6 × 1.8 × 1.7 cm. Due to the rarity of metastatic uterine sarcoma to the brain, this was believed to represent a meningioma and subsequently observed. Interval MRI scan revealed a significant increase in size of the right occipital mass to 2.3 cm with increased edema and mass effect. She underwent right occipital image guided craniotomy for resection of the mass. Histopathology confirmed UUS metastases. CONCLUSION: Randomized trials analyzing these treatment options are limited due to the rarity of this disease; therefore, a standard therapy is not established. Based on a review of the literature, this is only the fourth case reported of UUS metastatic to the brain.
format Online
Article
Text
id pubmed-3815079
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-38150792013-11-14 Undifferentiated uterine sarcoma metastatic to the brain Stofko, Douglas L Surg Neurol Int Case Report BACKGROUND: Undifferentiated uterine sarcoma (UUS) is a rare tumor with an aggressive growth pattern. They occur in women from 40 to 60 years and are generally characterized by poor prognosis, a high rate of local recurrence, and distant metastases. UUS accounts for 0.2% of all gynecological malignancies. Possible treatments include surgery, radiotherapy, and chemotherapy. CASE DESCRIPTION: A 65-year-old female with postmenopausal bleeding was found to have a uterine mass for which she underwent a total abdominal hysterectomy, bilateral salpingo-oophorectomy, and omentectomy. The pathologic evaluation was consistent with undifferentiated endometrial sarcoma. She began experiencing headaches with associated visual disturbances. Magnetic resonance imaging (MRI) of the brain showed a homogenous enhancing occipital dural-based mass measuring 1.6 × 1.8 × 1.7 cm. Due to the rarity of metastatic uterine sarcoma to the brain, this was believed to represent a meningioma and subsequently observed. Interval MRI scan revealed a significant increase in size of the right occipital mass to 2.3 cm with increased edema and mass effect. She underwent right occipital image guided craniotomy for resection of the mass. Histopathology confirmed UUS metastases. CONCLUSION: Randomized trials analyzing these treatment options are limited due to the rarity of this disease; therefore, a standard therapy is not established. Based on a review of the literature, this is only the fourth case reported of UUS metastatic to the brain. Medknow Publications & Media Pvt Ltd 2013-09-27 /pmc/articles/PMC3815079/ /pubmed/24231690 http://dx.doi.org/10.4103/2152-7806.119054 Text en Copyright: © 2013 Stofko DL http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Case Report
Stofko, Douglas L
Undifferentiated uterine sarcoma metastatic to the brain
title Undifferentiated uterine sarcoma metastatic to the brain
title_full Undifferentiated uterine sarcoma metastatic to the brain
title_fullStr Undifferentiated uterine sarcoma metastatic to the brain
title_full_unstemmed Undifferentiated uterine sarcoma metastatic to the brain
title_short Undifferentiated uterine sarcoma metastatic to the brain
title_sort undifferentiated uterine sarcoma metastatic to the brain
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815079/
https://www.ncbi.nlm.nih.gov/pubmed/24231690
http://dx.doi.org/10.4103/2152-7806.119054
work_keys_str_mv AT stofkodouglasl undifferentiateduterinesarcomametastatictothebrain